Initial management through the anal cancer multidisciplinary team meeting

Colorectal Disease

Volumn 13, Issue SUPPL. 1, 2011, Pages 21-28

  Renehan, A G ^a,b   O'Dwyer, S T ^a,b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CHEMORADIOTHERAPY; COLOSTOMY; CROHN DISEASE; HISTOPATHOLOGY; HUMAN; MEDICAL AUDIT; PATIENT SELECTION; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ANUS NEOPLASMS; HUMANS; PATIENT CARE TEAM;

EID: 78751697750     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2010.02495.x     Document Type: Article

References (52)

1. Office of National Statistics. (2007) Cancer registration statistics: four-digit codes [accessed 30 May 2010]
2. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-44.
3. Brewster DH, Bhatti LA. Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer 2006; 95: 87-90.
4. Robinson D, Coupland V, Moller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer 2009; 100: 527-31.
5. Anonymous. Anal cancer incidence rates increased in antiretroviral era. Rates increased for men and women. AIDS Alert 2006; 21: 22-3.
6. Renehan AG, Moran T, O'Dwyer S T. Trends in anal cancer incidence in England (1971 to 2005): an age-period-cohort analysis. Special Issue: Abstracts of the Association of Coloproctology of Great Britain and Ireland Annual Meeting, 8-11 June 2009, Harrogate, UK. Colorectal Disease 2009; 11 (Suppl. 1): 1-13, in press.
7. ACPGBI. (2007) The Association of Coloproctology of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. (3rd edn). [accessed 22 December 2010].
8. Engstrom PF, Arnoletti JP, Benson AB 3rd et al. NCCN clinical practice guidelines in oncology. Anal carcinoma. J Natl Compr Canc Netw 2010; 8: 106-20.
9. Fleshner PR, Chalasani S, Chang GJ, Levien DH, Hyman NH, Buie WD. Practice parameters for anal squamous neoplasms. Dis Colon Rectum 2008; 51: 2-9.
10. Glynne-Jones R, Northover JM, Cervantes A. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl 5): v87-92.
11. National Cancer Peer Review Programme. (2010) Manual for Cancer Services 2008; Colorectal Measures. NHS National Cancer Action Team, London.
12. Bartelink H, Roelofsen F, Eschwege F et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15: 2040-9.
13. Nilsson PJ, Svensson C, Goldman S, Ljungqvist O, Glimelius B. Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys 2005; 61: 92-102.
14. Renehan AG, Saunders MP, Schofield PF, O'Dwyer S T. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 2005; 92: 605-14.
15. UKCCCR. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996; 348: 1049-54.
16. Ajani JA, Winter KA, Gunderson LL et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008; 299: 1914-21.
17. Das P, Cantor SB, Parker CL et al. Long-term quality of life after radiotherapy for the treatment of anal cancer. Cancer 2010; 116: 822-9.
18. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999; 85: 1686-93.
19. Deniaud-Alexandre E, Touboul E, Tiret E et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 2003; 56: 1259-73.
20. Adami J, Gabel H, Lindelof B et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-7.
21. Patel HS, Silver AR, Northover JM. Anal cancer in renal transplant patients. Int J Colorectal Dis 2007; 22: 1-5.
22. Devon KM, Brown CJ, Burnstein M, McLeod RS. Cancer of the anus complicating perianal Crohn's disease. Dis Colon Rectum 2009; 52: 211-6.
23. Nilsson PJ, Ragnarsson-Olding BK. Importance of clear resection margins in anorectal malignant melanoma. Br J Surg 2010; 97: 98-103.
24. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FI, Trotti AI. (2009) AJCC Cancer Staging Manual. Springer, New York.
25. Fenger C, Frisch M, Marti MC, Parc R. (2000) Tumours of the anal canal. In: World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System (eds Hamilton SR, Aaltonen LA), pp. 145-55. IARC Press, Lyon.
26. Kuroda N, Tanida N, Ohara M et al. Anal canal adenocarcinoma with MUC5AC expression suggestive of anal gland origin. Med Mol Morphol 2007; 40: 50-3.
27. Haboubi NY, Edilbe MW, Hill J. Justification for staging of epidermoid anal carcinoma after salvage surgery: a pathological guideline. Colorectal Dis 2007; 9: 238-44.
28. Rasheed S, Yap T, Zia A, McDonald PJ, Glynne-Jones R. Chemo-radiotherapy: an alternative to surgery for squamous cell carcinoma of the rectum--report of six patients and literature review. Colorectal Dis 2009; 11: 191-7.
29. Allal AS, Obradovic M, Laurencet F et al. Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy. Cancer 1999; 85: 26-31.
30. Charnley N, Choudhury A, Chesser P, Cooper RA, Sebag-Montefiore D. Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy. Br J Cancer 2005; 92: 1221-5.
31. Dittmer DP. An appraisal of non-AIDS-defining cancers: comment on "Spectrum of Cancer Risk Late After AIDS Onset in the United States". Arch Intern Med 2010; 170: 1345-6.
32. Kreuter A, Potthoff A, Brockmeyer NH et al. Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. Br J Dermatol Feb 22 epub 2010; DOI:
33. Fraunholz I, Weiss C, Eberlein K, Haberl A, Rodel C. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy. Int J Radiat Oncol Biol Phys 2010; 76: 1425-32.
34. Hoffman R, Welton ML, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 1999; 44: 127-31.
35. Wexler A, Berson AM, Goldstone SE et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008; 51: 73-81.
36. Bharucha AE. Pelvic floor: anatomy and function. Neurogastroenterol Motil 2006; 18: 507-19.
37. Greene FL, Page DL, Fleming ID et al. (2002) AJCC Cancer Staging Manual. Springer, New York.
38. Gerard JP, Ayzac L, Hun D et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 1998; 46: 249-56.
39. Goh V, Gollub FK, Liaw J et al. Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? Int J Radiat Oncol Biol Phys 2010; 78: 715-21.
40. James R, Meadows H, Wan S. ACT II: the second UK phase III anal cancer trial. Clin Oncol (R Coll Radiol) 2005; 17: 364-6.
41. Roach SC, Hulse PA, Moulding FJ, Wilson R, Carrington BM. Magnetic resonance imaging of anal cancer. Clin Radiol 2005; 60: 1111-9.
42. Koh DM, Dzik-Jurasz A, O'Neill B, Tait D, Husband JE, Brown G. Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. Br J Radiol 2008; 81: 91-8.
43. Drudi FM, Raffetto N, De Rubeis M et al. TRUS staging and follow-up in patients with anal canal cancer. Radiol Med (Torino) 2003; 106: 329-37.
44. Otto SD, Lee L, Buhr HJ, Frericks B, Hocht S, Kroesen AJ. Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging. J Gastrointest Surg 2009; 13: 1292-8.
45. Tarantino D, Bernstein MA. Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system. Dis Colon Rectum 2002; 45: 16-22.
46. Rousseau DL Jr, Thomas CR Jr, Petrelli NJ, Kahlenberg MS. Squamous cell carcinoma of the anal canal. Surg Oncol 2005; 14: 121-32.
47. Damin DC, Rosito MA, Gus P et al. Sentinel lymph node procedure in patients with epidermoid carcinoma of the anal canal: early experience. Dis Colon Rectum 2003; 46: 1032-7.
48. Trautmann TG, Zuger JH. Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 2005; 7: 309-13.
49. Winton E, Heriot AG, Ng M et al. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer 2009; 100: 693-700.
50. de Bree E, van Ruth S, Dewit LG, Zoetmulder FA. High risk of colostomy with primary radiotherapy for anal cancer. Ann Surg Oncol 2007; 14: 100-8.
51. Glynne-Jones R. Anal cancer: one step forward--two steps sideways!. Eur J Cancer 2009; 45: 2728-30.
52. DoH (2008) National Cancer Survivorship Initiative. [accessed 31 May 2010].